Ayman El-kattan PhD

Dr. Ayman El-Kattan is Associate Research Fellow at the Pharmacokinetics, Dynamics, and Metabolism Department, Pfizer Inc. Cambridge Laboratories. He led Pfizer efforts in the emerging area of drug transporters with emphasis on developing in vitro and in silico tools to improve the ability to predict transporter-mediated clearance and DDI in men. Dr. El-Kattan earned his bachelor's degree in pharmacy with distinction from the University of Jordan and a Ph.D. in Basic Pharmaceutical Sciences at the University of South Carolina in the US. His main research interests are focused on understanding the factors that affect drug disposition and oral bioavailability with emphasis on transporters. Also, it involves studying the utility of physiological-based pharmacokinetic modeling (PBPK) tools e.g. SimCYP in projecting drug disposition and drug-drug interaction liabilities in man for new molecular entities (NME).

Dr. El-Kattan is an Adjunct Associate Professor at the College of Pharmacy-University of Rhode Island in Rhode Island, US, where he lectures in the graduate‐level pharmacokinetics and drug development courses and serves as an external advisor on dissertation committees. He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and serves on the executive committee of the physical pharmacy and biopharmaceutics and Northeastern Regional Discussion Group (NERDG) sections of AAPS. He has been invited speaker over 30 times at national and international conferences and meetings and has published over 100 papers in peer-reviewed journals, book chapters, and proceedings.